8156 — Sinopharm Tech Holdings Balance Sheet
0.000.00%
- HK$133.71m
- HK$272.36m
- HK$61.25m
- 17
- 30
- 69
- 29
Annual balance sheet for Sinopharm Tech Holdings, fiscal year end - June 30th, HKD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 7.48 | 2.99 | 1.78 | 2.64 | 6.95 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 26.6 | 42.4 | 22.9 | 28.6 | 26.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 49.6 | 48.1 | 27 | 38.1 | 49.1 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 28.3 | 5.19 | 1.16 | 3.88 | 2.6 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 136 | 76.9 | 33.5 | 44.5 | 51.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 273 | 250 | 213 | 249 | 68.4 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Liabilities | 275 | 244 | 206 | 244 | 88.6 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -139 | -167 | -173 | -199 | -36.9 |
Total Liabilities & Shareholders' Equity | 136 | 76.9 | 33.5 | 44.5 | 51.7 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |